After acid gel-chromatography cerebrospinal fluid and serum levels of immunoreactive insulin-like growth factor 1 and 2 (IGF-1 and IGF-2) were determined in patients with dementia of the Alzheimer type (AD) and in healthy subjects. The AD CSF levels of immunoreactive IGF-1 did not differ from the subjects but the levels of immunoreactive IGF-2 was significantly elevated in both serum and CSF in the AD patient group. Additionally immunoreactive IGF-1 in AD serum was found to be significantly elevated. To characterize the CSF IGF binding protein activity (IGFBP), ligand blotting was performed on whole CSF from AD patients and subjects. The results demonstrate two major forms of IGFBP in CSF with approximate molecular weights of 33 KDa and 30 KDa. The two IGFBP forms are suggested to represent IGFBP-2 and IGFBP-6. A highly significant increase in both the IGFBPs was observed in the CSF of the AD patients compared to the healthy subjects.

sensory quality, but their practicability is questionable because a correlation coefficient indicates only an association and not a cause-and-effect relationship. More data are required to prove the practicability of these tests.From numerous tests and data presented in this study, the following guidelines are suggested: grade I II III quality prime acceptable poor days in ice 0-8 9-11 >11 MOR 8.7-7.4 <7.4-5.0 <5 NPN, mg/100 g 520-400 <400-345 <345 AAN, mg/100 g 360-230 <230-210 <210 TVB, mg/100g 9.0-22.5 >22.5-26.0 >26.0 TMA-N, mg/100 g 0.3-0.7 >0.7-1.1 >1.1 Pi, mg/100 g 295-144 <144-118 <118 PH

No abstract

The ontogeny of lactogen receptors in brain, adipose, liver, kidney, adrenal gland, mammary gland, ovarian and uterine tissues of pregnant rabbits was evaluated in this study using 125I bovine prolactin as tracer. Brain and adipose tissues were found to have very low receptor numbers throughout pregnancy (less than 20 fmol/mg of protein), while liver and kidney had higher but constant levels of receptor through the same period (200 and 100 fmol/mg of protein, respectively). Mammary gland and adrenal gland tissues exhibited sharp increases in prolactin binding between 15 and 17 days with both having peak receptor binding at 17 days of around 200 fmol/mg of protein. Ovarian and uterine receptor binding increased slowly after day five of pregnancy and reached peak levels of approximately 225 fmol/mg of protein at day 20. Scatchard analysis of the binding of protein in the tissues having increased binding during the course of pregnancy, revealed that its affinity for sites in these tissues was the same at 5 and 20 days of gestation, indicating the rise in binding to be a result of increased numbers of available receptors. Sub-organ localization studies found the binding of prolactin to adrenal gland, ovary and uterus to be essentially located in adrenal cortex, nonluteal ovary and endometrium. Incubation of membranes from each of the tissues showing significant change during pregnancy, from several time points of pregnancy, with 5.0 M MgCl2 produced little change in apparent receptor numbers; suggesting that receptor occupancy levels of endogenous prolactin was low.